- Home
- BNR vs MOBX Comparison
BNR vs MOBX Comparison
Compare BNR & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- MOBX
- Stock Information
- Founded
- BNR 2014
- MOBX 2020
- Country
- BNR China
- MOBX United States
- Employees
- BNR N/A
- MOBX N/A
- Industry
- BNR Medical Specialities
- MOBX
- Sector
- BNR Health Care
- MOBX
- Exchange
- BNR Nasdaq
- MOBX Nasdaq
- Market Cap
- BNR 29.1M
- MOBX 29.6M
- IPO Year
- BNR 2020
- MOBX N/A
- Fundamental
- Price
- BNR $3.25
- MOBX $0.70
- Analyst Decision
- BNR
- MOBX
- Analyst Count
- BNR 0
- MOBX 0
- Target Price
- BNR N/A
- MOBX N/A
- AVG Volume (30 Days)
- BNR 68.1K
- MOBX 143.2K
- Earning Date
- BNR 06-02-2025
- MOBX 06-03-2025
- Dividend Yield
- BNR N/A
- MOBX N/A
- EPS Growth
- BNR N/A
- MOBX N/A
- EPS
- BNR N/A
- MOBX N/A
- Revenue
- BNR $70,669,261.00
- MOBX $10,692,000.00
- Revenue This Year
- BNR $136.32
- MOBX N/A
- Revenue Next Year
- BNR N/A
- MOBX N/A
- P/E Ratio
- BNR N/A
- MOBX N/A
- Revenue Growth
- BNR N/A
- MOBX 450.28
- 52 Week Low
- BNR $2.18
- MOBX $0.55
- 52 Week High
- BNR $7.90
- MOBX $2.51
- Technical
- Relative Strength Index (RSI)
- BNR 57.77
- MOBX 44.58
- Support Level
- BNR $2.49
- MOBX $0.68
- Resistance Level
- BNR $3.05
- MOBX $0.85
- Average True Range (ATR)
- BNR 0.34
- MOBX 0.07
- MACD
- BNR 0.15
- MOBX 0.00
- Stochastic Oscillator
- BNR 87.61
- MOBX 28.03
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.